OptiCell Solutions News - Senaste nyheterna från Opticell Solutions

Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs)

2026-08-06

— PRESS RELEASE — Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs) – but achieving this will require more than world-class research.…

OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration

2026-02-05

— PRESS RELEASE — OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration Huddinge, Sweden 05-FEB-2026 OptiCell Solutions today announces the successful delivery of its first…

OptiCell Solutions enters into new collaboration

2025-12-02

— PRESS RELEASE — OptiCell Solutions initiates collaboration with NextCell Pharma – strengthening operations in cell and gene therapies Huddinge, Sweden 02-DEC-2025 OptiCell Solutions AB (“OptiCell”) is pleased to announce…

Two-year collaboration with Karolinska Institutet

2025-10-29

PRESS RELEASE 29-OCT-2025_OptiCell Solutions We are proud to announce our new research collaboration with Karolinska Institutet. Through a two-year agreement, OptiCell Solutions will supply high-quality apheresis generated cell material to…

OptiCell Solutions AB announce the collaboration with CTC, Clinical Trial Consultants AB

2025-06-25

PRESS RELEASE OptiCell Solutions AB announce the collaboration with CTC, Clinical Trial Consultants AB Huddinge, Sweden 25-JUN-2025 Exciting News from OptiCell Solutions We are happy to announce the next step…

Mr. Henrik Fahlander as the Clinical Apheresis Specialist

2025-01-09

PRESSRELEASE, Huddinge, Sweden 2025-01-09 OptiCell Solutions AB announce the addition of Mr. Henrik Fahlander as the Clinical Apheresis Specialist OptiCell Solutions AB is delighted to announce the addition of Mr.…

OptiCell Solutions – A Key Player in Cell and Gene Therapy

2024-11-18

PRESSRELEASE “OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg” Flemingsberg Science Foundation, Huddinge, Sweden 18-Nov-2024 Flemingsberg continues to be a natural choice for knowledge-intensive…

Dr. Axdorph Nygell as the Medically Responsible Person

2024-11-04

PRESSRELEASE, Huddinge, Sweden 2024-11-04 OptiCell Solutions AB announce the addition of Dr. Ulla Axdorph Nygell as the Medically Responsible Person OptiCell Solutions AB is delighted to announce the addition of…

Exciting news from OptiCell Solutions

2024-10-23

PRESS RELEASE, Huddinge 23-OCT-2024 Exciting News from OptiCell Solutions! We are happy to announce the next step in our journey toward advancing patient care by officially partnering with CliniQnect. Together,…

OptiCell Solutions participates in ATMP Sweden 2024, Malmö 25-25 November

2024-10-15

PRESS RELEASE, Huddinge Sweden 15-OCT-2024 OptiCell Solutions improving access to high quality target cells for Cell and Gene Therapy ATMP Sweden 2024 in Malmö 25-26 November Of course, we´re going!…

News

Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs)

OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration

OptiCell Solutions enters into new collaboration

Two-year collaboration with Karolinska Institutet

OptiCell Solutions AB announce the collaboration with CTC, Clinical Trial Consultants AB

Mr. Henrik Fahlander as the Clinical Apheresis Specialist

OptiCell Solutions – A Key Player in Cell and Gene Therapy

Dr. Axdorph Nygell as the Medically Responsible Person

Exciting news from OptiCell Solutions

OptiCell Solutions participates in ATMP Sweden 2024, Malmö 25-25 November

Visiting Address

Mailing Address

Registration number: 559473-6125

Contact

Swedish